Want to see SG:1B1 full AI Analyst Report?
HC Surgical Specialists Ltd (1B1) Share Price & Analysis
1B1 Stock Chart & Stats
- Day’s Range
- SGD 0.33 - SGD 0.34
- 52-Week Range
- SGD 0.33 - SGD 0.40
- Previous Close
- SGD 0.34
- Volume
- N/A
- Average Volume (3M)
- 11.21K
- Market Cap
- SGD 51.53M
- Enterprise Value
- SGD 52.57M
- Total Cash (Recent Filing)
- SGD 6.96M
- Total Debt (Recent Filing)
- SGD 2.40M
- Price to Earnings (P/E)
- 8.0
- Beta
- 0.22
- Next Earnings
- Jan 14, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Oct 21, 2026
- Dividend Yield
- 6.12%
Bulls Say, Bears Say
Bulls Say
Robust Cash Generation
Consistently positive operating and free cash flow indicates that reported profits convert into usable cash, supporting reinvestment and shareholder returns. The close relationship between free cash flow and net income also suggests earnings quality is solid, while strong 2026 free cash flow growth adds support to near-term financial resilience.
Improving Balance Sheet
Materially lower debt relative to equity reduces balance-sheet pressure and improves financial flexibility. The combination of improving leverage and a larger equity base should leave the company better positioned to fund operations, absorb business fluctuations, and allocate capital without relying as heavily on additional borrowing.
Strong Profitability
Very high gross margins and a strong 2025 net profit margin indicate favorable underlying economics and meaningful profit conversion. This profitability can provide internal funding for the business and create a cushion against moderate revenue variability, although maintaining these levels remains important to future earnings durability.
Bears Say
Uneven Revenue Growth
The multi-year pattern of revenue declines followed by a later rebound shows that growth has not been consistently predictable. Uneven top-line performance can make capacity planning and earnings forecasting more difficult, and it raises the importance of sustaining the recent recovery rather than treating the 2026 improvement as an established trend.
Earnings Volatility
Profit declines in 2023–2024 followed by recovery in 2025–2026 indicate that earnings power has varied materially over time. Such volatility can weaken confidence in the durability of current profitability, make shareholder returns less predictable, and increase dependence on continued improvement in operating performance.
Variable Cash-flow Coverage
Lower operating-cash-flow coverage in 2023–2024 suggests that cash conversion was not equally strong in every period. Although overall cash generation remains robust, recurring variability could reduce the reliability of internally funded investment or distributions if weaker conversion reappears during future periods of profit pressure.
HC Surgical Specialists Ltd News
HC Surgical Specialists Delivers Steady Revenue, Lower FY2026 Profit but Maintains Dividend and Expands Specialist Network
The latest update is out from HC Surgical Specialists Ltd ( ($SG:1B1) ). HC Surgical Specialists Limited reported FY2026 revenue of S$19.38 million, up 1.4% year-on-year, while profit attributable to
1B1 FAQ
What was HC Surgical Specialists Ltd’s price range in the past 12 months?
What is HC Surgical Specialists Ltd’s market cap?
When is HC Surgical Specialists Ltd’s upcoming earnings report date?
How were HC Surgical Specialists Ltd’s earnings last quarter?
Is HC Surgical Specialists Ltd overvalued?
Does HC Surgical Specialists Ltd pay dividends?
What is HC Surgical Specialists Ltd’s EPS estimate?
How many shares outstanding does HC Surgical Specialists Ltd have?
What happened to HC Surgical Specialists Ltd’s price movement after its last earnings report?
Which hedge fund is a major shareholder of HC Surgical Specialists Ltd?
What is the TipRanks Smart Score and how is it calculated?
Company Description
HC Surgical Specialists Ltd
HC Surgical Specialists Limited, an investment holding company, primarily delivers a diverse spectrum of medical services across Singapore. Through its network of clinics, the company specializes in endoscopic procedures, such as gastroscopies and colonoscopies, in addition to providing general surgical services with a notable focus on colorectal issues. Their expertise further extends to treating a variety of conditions, including haemorrhoids, anal fissures, hernias, anal abscesses, cholecystitis, anal fistulas, appendicitis, colorectal and gastric cancers, lipomas, and cysts, utilizing advanced techniques like vein laser vascular therapy and laparoscopy. Moreover, the company offers extensive orthopedic services. These address concerns such as joint pain, sports injuries, osteoarthritis, rotator cuff tears, trigger finger, tenosynovitis, tunnel syndrome, and various wounds or lumps. Surgical interventions include joint replacements, arthroscopic procedures, knee osteotomy, realignment surgery, endoscopic spine surgery, disc replacements, spinal decompression, and fracture management, supported by orthobiologic injections. Beyond clinical care, the company provides comprehensive home care services, encompassing medical, nursing, physiotherapy, speech, occupational therapy, and ambulance support. Their community health initiatives include health screenings, management of acute and chronic conditions, pre-employment check-ups, and participation in public health schemes such as the 'swab and send home' program, the community health assist scheme, and COVID-19 testing. To support accurate diagnosis, a full array of diagnostic tests is available, including blood work, X-rays, ultrasounds, CT scans, and MRIs. The company was founded in Singapore in 2015, where it continues to be headquartered.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Sieu Min Heah Surgen FRCSEd BCh
- Employees
- 18
- Website
- www.hcsurgicalspecialists.com
- Address
- 233 River Valley Road, Singapore, CE, 238291, SG
HC Surgical Specialists Ltd (1B1) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 5 | 3 | 14 |
| Technical Analysis | 5 | 3 | 2 |
| Moving Averages | 0 | 0 | 12 |








